Krsnaa Diagnostics Limited stock analysis
Want to see IN:KRSNAA full AI Analyst Report?
Krsnaa Diagnostics Limited (KRSNAA) Stock Price & Analysis
KRSNAA Stock Chart & Stats
- Day’s Range
- INR 510.10 - INR 523.85
- 52-Week Range
- INR 462.10 - INR 834.90
- Previous Close
- INR 514.40
- Volume
- N/A
- Average Volume (3M)
- 5,522
- Market Cap
- INR 16.69B
- Enterprise Value
- INR 22.30B
- Total Cash (Recent Filing)
- INR 1.92B
- Total Debt (Recent Filing)
- INR 5.96B
- Price to Earnings (P/E)
- 17.2
- Beta
- 0.66
- Next Earnings
- Feb 14, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 18, 2026
- Dividend Yield
- 0.39%
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
Consistent revenue expansion indicates sustained demand for Krsnaa Diagnostics’ pathology and radiology services. Continued top-line growth can increase network utilization, strengthen its position in institutional healthcare delivery, and provide a durable base for operating leverage over the next several quarters.
Deleveraged Balance Sheet
Lower leverage and declining total debt improve financial flexibility and reduce the balance-sheet burden associated with expansion. A sizable equity base gives the company more capacity to support diagnostic infrastructure investment and absorb operating volatility without relying as heavily on external funding.
Positive Operating Cash Flow
Positive operating cash flow across the reported period shows that the core diagnostic operations generate cash before capital investment. This supports ongoing service delivery and provides an internal funding source, even though the company still faces substantial investment and working-capital demands.
Bears Say
Persistent Negative Free Cash Flow
Repeatedly negative free cash flow indicates that operating cash generation has not consistently covered capital investment and other cash requirements. This can constrain self-funded expansion, increase dependence on balance-sheet capacity, and make future growth more sensitive to funding availability.
Volatile Profitability
The sharp margin deterioration in 2024 followed by recovery shows that earnings performance and the cost structure have not been consistently stable. Such volatility makes future profit conversion less predictable and may weaken the durability of returns even while revenue continues to grow.
Inconsistent Cash Conversion
Weak and inconsistent conversion of reported profits into cash reduces the quality and flexibility of earnings. It may leave less internally generated funding for diagnostic-center expansion, increase reliance on available financing, and make accounting performance less representative of spendable cash resources.
Krsnaa Diagnostics Limited News
KRSNAA FAQ
What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
What is Krsnaa Diagnostics Limited’s market cap?
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Is Krsnaa Diagnostics Limited overvalued?
Does Krsnaa Diagnostics Limited pay dividends?
What is Krsnaa Diagnostics Limited’s EPS estimate?
How many shares outstanding does Krsnaa Diagnostics Limited have?
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services. The company was incorporated in 2010 and is based in Pune, India.
- Sector
- General
- Industry
- Medical - Diagnostics & Research
- CEO
- Mitesh Dave
- Employees
- 3,296
- Website
- krsnaadiagnostics.com
- Address
- S.No.243,A-Hissa No.6/6, Pune, MH, 411019, IN
Krsnaa Diagnostics Limited (KRSNAA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 10 | 5 | 7 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 6 | 0 | 6 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:LALPATHLABDr. Lal PathLabs Limited | ||
| IN:METROPOLISMetropolis Healthcare Ltd. | ||
| IN:SURAKSHASuraksha Diagnostic Ltd. | ||
| IN:THYROCAREThyrocare Technologies Ltd | ||
| IN:VIJAYAVijaya Diagnostic Centre Ltd. |










